Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qidan Bimin Wan for seasonal allergic rhinitis (lung-spleen qi deficiency)
CTR20130233Phase 3Completed
- Sponsor
- Shanxi Yangwenshui Pharmaceutical
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Qidan Bimin Pill in seasonal allergic rhinitis (SAR), sponsored by Shanxi Yangwenshui Pharmaceutical. Started May 2014; status: completed.
02
Drugs
Qidan Bimin Pill
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on CTR20130233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130233.